Therapeutic Advances in Childhood Leukemia Consortium
21 clinical trials · Sponsor
◉ Watch Therapeutic Advances in Childhood Leukemia Consortium
| Record | Firm | Date |
|---|---|---|
| Trial of Revumenib Plus FLA Chemotherapy for Children With Relapsed or Refractory NUP98-rearranged AML." (NCT07686107) | Therapeutic Advances in Childhood Leukemia Consortium | 2026-08-31 |
| A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia (NCT05849662) | Therapeutic Advances in Childhood Leukemia Consortium | 2024-10-11 |
| Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies (NCT05476770) | Therapeutic Advances in Childhood Leukemia Consortium | 2022-11-11 |
| Nivolumab in Combination With 5-azacytidine in Childhood Relapsed/Refractory AML (NCT03825367) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-11-29 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (NCT03817320) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-02-12 |
Track Therapeutic Advances in Childhood Leukemia Consortium automatically
Every clearance here is in the API, with alerts when new ones post.